Nothing Special   »   [go: up one dir, main page]

AU2014902730A0 - Methods of inhibiting transmembrane proteins - Google Patents

Methods of inhibiting transmembrane proteins

Info

Publication number
AU2014902730A0
AU2014902730A0 AU2014902730A AU2014902730A AU2014902730A0 AU 2014902730 A0 AU2014902730 A0 AU 2014902730A0 AU 2014902730 A AU2014902730 A AU 2014902730A AU 2014902730 A AU2014902730 A AU 2014902730A AU 2014902730 A0 AU2014902730 A0 AU 2014902730A0
Authority
AU
Australia
Prior art keywords
methods
transmembrane proteins
inhibiting
inhibiting transmembrane
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014902730A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Vincents Institute of Medical Research
University of Melbourne
Original Assignee
St Vincents Institute of Medical Research
University of Melbourne
Filing date
Publication date
Application filed by St Vincents Institute of Medical Research, University of Melbourne filed Critical St Vincents Institute of Medical Research
Publication of AU2014902730A0 publication Critical patent/AU2014902730A0/en
Abandoned legal-status Critical Current

Links

AU2014902730A 2014-07-15 Methods of inhibiting transmembrane proteins Abandoned AU2014902730A0 (en)

Publications (1)

Publication Number Publication Date
AU2014902730A0 true AU2014902730A0 (en) 2014-07-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP3102576B8 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
EP3127357B8 (en) System of living
HK1231400A1 (en) Selective reduction of proteins
EP3116851A4 (en) Analogs of fexaramine and methods of making and using
EP3108229A4 (en) Nanopore-based analysis of protein characteristics
EP3236772A4 (en) Methods of purifying recombinant proteins
EP3131468A4 (en) Method of imaging
EP3142667A4 (en) Methods for inhibiting necroptosis
EP3510172A4 (en) Methods of detecting lentivirus
EP3166979A4 (en) Ultrafiltration of polyisoolefin copolymers
EP3166931A4 (en) An improved process for the preparation of enzalutamide
EP3149176A4 (en) Methods for altering polypeptide expression
EP3458171A4 (en) Methods of affecting separation
EP3164410B8 (en) Protein recovery
EP3230280A4 (en) Process for preparation of luliconazole
EP3113773A4 (en) Crystalline forms of grapiprant
EP3139956A4 (en) Methods of using anti-ang2 antibodies
EP3244901A4 (en) Methods for isolation of platelets
EP3218354A4 (en) Novel methods
EP2962726B8 (en) System for excitation of phantom sensations
EP3178923A4 (en) Use of susd2 protein as marker
EP3465203A4 (en) Methods of immunotherapy
EP3180296A4 (en) Methods of producing alkylfurans
IL252712A0 (en) Method of protein manufacture
EP3149024A4 (en) Derivatives of dolaproine-dolaisoleuine peptides